Daniel L. Kisner's Insider Trades & SAST Disclosures
Daniel L. Kisner's most recent trade in Oncternal Therapeutics Inc was a trade of 2,200 Stock Options done . Disclosure was reported to the exchange on June 20, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Daniel L. Kisner.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncternal Therapeutics Inc | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 2,200 | 2,200 | - | - | Stock Options | |
| Dynavax Technologies Corp. | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 5,357 | 17,571 (0%) | 0% | 0 | Common Stock | |
| Oncternal Therapeutics Inc | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 25,000 | 25,000 | - | - | Stock Options | |
| Histogen Inc | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 6,835 | 6,835 | - | - | Stock Option (right to buy) | |
| Zynerba Pharmaceuticals Inc | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 71,736 | 71,736 | - | - | Stock Option (right to buy) | |
| Zynerba Pharmaceuticals Inc | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 47,824 | 75,893 (0%) | 0% | 0 | Common Stock | |
| Zynerba Pharmaceuticals Inc | Daniel L. Kisner | Director | Sale of securities on an exchange or to another person at price $ 0.35 per share. | 13 Jun 2023 | 115 | 75,778 (0%) | 0% | 0.3 | 40 | Common Stock |
| Dynavax Technologies Corp. | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 5,357 | 12,214 (0%) | 0% | 0 | Common Stock | |
| Oncternal Therapeutics Inc | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 25,000 | 25,000 | - | - | Stock Options | |
| Zynerba Pharmaceuticals Inc | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 34,663 | 34,663 | - | - | Stock Option (right to buy) | |
| Zynerba Pharmaceuticals Inc | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 23,109 | 28,109 (0%) | 0% | 0 | Common Stock | |
| Zynerba Pharmaceuticals Inc | Daniel L. Kisner | Director | Sale of securities on an exchange or to another person at price $ 1.00 per share. | 14 Jun 2022 | 40 | 28,069 (0%) | 0% | 1 | 40 | Common Stock |
| Histogen Inc | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 1,000 | 1,000 | - | - | Stock Option (right to buy) | |
| Dynavax Technologies Corp. | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 22,500 | 22,500 | - | - | Option (Right to Buy) | |
| Dynavax Technologies Corp. | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 5,357 | 5,357 | - | - | Restricted Stock Unit | |
| Histogen Inc | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Zynerba Pharmaceuticals Inc | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Zynerba Pharmaceuticals Inc | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 5,000 | 5,000 (0%) | 0% | 0 | Common Stock | |
| Dynavax Technologies Corp. | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 25,000 | 25,000 | - | - | Option (Right to Buy) | |
| Oncternal Therapeutics Inc | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 25,000 | 25,000 | - | - | Stock Options | |
| Histogen Inc | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Oncternal Therapeutics Inc | Daniel L. Kisner | Director | Purchase of securities on an exchange or from another person at price $ 2.38 per share. | 21 Jul 2020 | 10,000 | 10,000 (0%) | 0% | 2.4 | 23,825 | Common Stock |
| Oncternal Therapeutics Inc | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2020 | 5,000 | 5,000 | - | - | Warrants | |
| Oncternal Therapeutics Inc | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 15,000 | 30,000 | - | - | Stock Options | |
| Zynerba Pharmaceuticals Inc | Daniel L. Kisner | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Dynavax Technologies Corp. | Daniel L. Kisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2020 | 25,000 | 25,000 | - | - | Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges